Cargando…

A diagnostic test to examine early improvement as a predictor of later response to lurasidone in bipolar depression

INTRODUCTION: Kato et al. reported results of a 6‐week, double‐blind, randomized, placebo‐controlled trial of lurasidone in adults with bipolar depression (BDep). AIM: We performed a post hoc analysis using data from the lurasidone trial to predict later responses from early improvements. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishi, Taro, Nakamura, Hiroshi, Kato, Tadafumi, Iwata, Nakao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Micro Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009426/ https://www.ncbi.nlm.nih.gov/pubmed/36632763 http://dx.doi.org/10.1002/npr2.12319

Ejemplares similares

Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
por: Kishi, Taro, et al.
Publicado: (2020)

Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan
por: Kishi, Taro, et al.
Publicado: (2020)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

De novo UNC13B mutation identified in a bipolar disorder patient increases a rare exon‐skipping variant
por: Nakamura, Takumi, et al.
Publicado: (2018)

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
por: Kishi, Taro, et al.
Publicado: (2021)

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta‐analysis of double‐blind, randomized, placebo‐controlled trials with an enrichment design
por: Oya, Kazuto, et al.
Publicado: (2019)

Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study
por: Kishi, Taro, et al.
Publicado: (2021)

Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
por: Kato, Tadafumi, et al.
Publicado: (2020)

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study
por: Kishi, Taro, et al.
Publicado: (2019)

Lurasidone for the treatment of bipolar depression: an evidence-based review
por: Franklin, Rachel, et al.
Publicado: (2015)

Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015)

Cell-type-specific DNA methylation analysis of the frontal cortices of mutant Polg1 transgenic mice with neuronal accumulation of deleted mitochondrial DNA
por: Sugawara, Hiroko, et al.
Publicado: (2022)

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
por: Fornaro, Michele, et al.
Publicado: (2017)

Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study
por: Higuchi, Teruhiko, et al.
Publicado: (2021)

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression
por: Loebel, Antony, et al.
Publicado: (2015)

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice
por: Amada, Naoki, et al.
Publicado: (2023)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression
por: Singh, Manpreet K., et al.
Publicado: (2023)

The lateral habenula is critically involved in histamine-induced itch sensation
por: Ko, Hyoung-Gon
Publicado: (2020)

PS37. Lurasidone in the Treatment of Bipolar Depression: Effect of Baseline Depression Severity on Clinical Outcome
por: Pikalov, Andrei, et al.
Publicado: (2016)

Elevated depressive symptoms among newer and younger healthcare workers in Japan during the COVID‐19 pandemic
por: Katsuta, Narimasa, et al.
Publicado: (2021)

Serial case report of high seizure threshold patients that responded to the lengthening of pulse width in ECT
por: Katagai, Hiroshi, et al.
Publicado: (2021)

Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis
por: Wang, Junmei, et al.
Publicado: (2021)

Characteristic association of symbol coding test score with occupational function in Japanese patients with schizophrenia
por: Watanabe, Yukako, et al.
Publicado: (2023)

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression
por: DelBello, Melissa P., et al.
Publicado: (2021)

High frequency optogenetic activation of inputs to the lateral amygdala forms distant association with foot-shock
por: Li, Fei, et al.
Publicado: (2020)

Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations
por: Fife, Daniel, et al.
Publicado: (2022)

TULIP study: Trail of Lurasidone in bipolar disorder in Pakistan()
por: Khan, Nasar, et al.
Publicado: (2021)

Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials
por: Kishi, Taro, et al.
Publicado: (2016)

Resolvin D2 attenuates chronic pain–induced depression‐like behavior in mice
por: Suzuki, Hiroe, et al.
Publicado: (2021)

Loss of endosomal recycling factor RAB11 coupled with complex regulation of MAPK/ERK/AKT signaling in postmortem spinal cord specimens of sporadic amyotrophic lateral sclerosis patients
por: Mitra, Joy, et al.
Publicado: (2019)

Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials
por: Rajagopalan, Krithika, et al.
Publicado: (2016)

Effects of age on suicide attempts by medication in patients transferred to the emergency rooms of two advanced medical centers: A retrospective chart review of the DJ project
por: Sasaki, Taro, et al.
Publicado: (2023)

Association between eating balanced meals and depressive symptoms in Japanese hospital workers during the COVID‐19 pandemic
por: Miki, Takako, et al.
Publicado: (2022)

Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis
por: Magota, Hirotoshi, et al.
Publicado: (2021)

Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania
por: Ikeda, Masashi, et al.
Publicado: (2022)

CCR2 is localized in microglia and neurons, as well as infiltrating monocytes, in the lumbar spinal cord of ALS mice
por: Komiya, Hiroyasu, et al.
Publicado: (2020)

Early manifestation of depressive‐like behavior in transgenic mice that express dementia with Lewy body‐linked mutant β‐synuclein
por: Fujita, Masayo, et al.
Publicado: (2018)

Oxytocin treatment improves dexamethasone‐induced depression‐like symptoms associated with enhancement of hippocampal CREB‐BDNF signaling in female mice
por: Mori, Masayoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2fqsn97e27h9s7s3j9bs44f6uu